MA32073B1 - Systeme d'administration de medicament contenant de l'oestradiol - Google Patents
Systeme d'administration de medicament contenant de l'oestradiolInfo
- Publication number
- MA32073B1 MA32073B1 MA33078A MA33078A MA32073B1 MA 32073 B1 MA32073 B1 MA 32073B1 MA 33078 A MA33078 A MA 33078A MA 33078 A MA33078 A MA 33078A MA 32073 B1 MA32073 B1 MA 32073B1
- Authority
- MA
- Morocco
- Prior art keywords
- administration
- containing estradiol
- drugs containing
- tablets
- estradiol
- Prior art date
Links
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 title abstract 2
- 229960005309 estradiol Drugs 0.000 title abstract 2
- 229930182833 estradiol Natural products 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 230000000116 mitigating effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000010409 thin film Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Reproductive Health (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
L'invention concerne des systèmes d'administration de médicament qui se présentent sous la forme de films minces solubles dans l'eau (cachets) contenant de l'estradiol, ou les dérivés de celui-ci, en faibles quantités. Les cachets de l'invention sont appropriés pour le traitement, l'atténuation ou la prévention d'un état physique causé par l'insuffisance des taux d'oestrogènes endogènes chez un mammifère femelle.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2830208P | 2008-02-13 | 2008-02-13 | |
| EP08002633 | 2008-02-13 | ||
| PCT/EP2009/051303 WO2009101021A2 (fr) | 2008-02-13 | 2009-02-05 | Système d'administration de médicament contenant de l'estradiol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA32073B1 true MA32073B1 (fr) | 2011-02-01 |
Family
ID=39365963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA33078A MA32073B1 (fr) | 2008-02-13 | 2010-08-12 | Systeme d'administration de medicament contenant de l'oestradiol |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20110097405A1 (fr) |
| EP (1) | EP2249803A2 (fr) |
| JP (1) | JP2011511823A (fr) |
| KR (1) | KR20100125309A (fr) |
| CN (1) | CN101945646A (fr) |
| AR (1) | AR070375A1 (fr) |
| AU (1) | AU2009214193A1 (fr) |
| BR (1) | BRPI0908477A2 (fr) |
| CA (1) | CA2714340A1 (fr) |
| CL (1) | CL2009000326A1 (fr) |
| CO (1) | CO6290633A2 (fr) |
| CR (1) | CR11632A (fr) |
| DO (1) | DOP2010000252A (fr) |
| EA (1) | EA201001245A1 (fr) |
| EC (1) | ECSP10010400A (fr) |
| IL (1) | IL206640A0 (fr) |
| MA (1) | MA32073B1 (fr) |
| MX (1) | MX2010008940A (fr) |
| NZ (1) | NZ586666A (fr) |
| PA (1) | PA8816001A1 (fr) |
| PE (1) | PE20091471A1 (fr) |
| TN (1) | TN2010000302A1 (fr) |
| TW (1) | TW200940095A (fr) |
| UA (1) | UA102680C2 (fr) |
| UY (1) | UY31660A1 (fr) |
| WO (1) | WO2009101021A2 (fr) |
| ZA (1) | ZA201006517B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101310710B1 (ko) * | 2011-03-23 | 2013-09-27 | 한미약품 주식회사 | 오메가-3 지방산 에스테르 및 HMG-CoA 환원효소 억제제를 포함하는 경구용 복합 조성물 |
| GB201200062D0 (en) | 2012-01-04 | 2012-02-15 | Innotesto Bvba | Estradiol oromucosal liquid compositions |
| AU2012385956B2 (en) | 2012-07-23 | 2017-03-30 | Crayola, Llc | Dissolvable films and methods of using the same |
| HK1247283A1 (zh) * | 2015-03-02 | 2018-09-21 | 科罗纳里康赛普茨有限责任公司 | 用於peg代谢物及peg分解产物检测的化合物及方法 |
| CN119055659A (zh) * | 2024-09-03 | 2024-12-03 | 南通大学 | 17α雌二醇或其化学修饰衍生物在制备预防和/或治疗男性性腺功能低下的药物中的应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4136162A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| JPS56140915A (en) * | 1980-04-07 | 1981-11-04 | Yamanouchi Pharmaceut Co Ltd | Pharmaceutical preparation for solid drug |
| DE3347125A1 (de) * | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption |
| US4764378A (en) * | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
| US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
| US5073374A (en) * | 1988-11-30 | 1991-12-17 | Schering Corporation | Fast dissolving buccal tablet |
| ATE155681T1 (de) * | 1992-05-18 | 1997-08-15 | Minnesota Mining & Mfg | Einrichtung zur transmucosalen wirkstoffabgabe |
| DE4426709A1 (de) * | 1994-07-20 | 1996-01-25 | Schering Ag | Steroidale Sexualhormone enthaltende feste Arzneiformen |
| DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
| CH693255A5 (de) * | 1997-06-13 | 2003-05-15 | Eprova Ag | Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels. |
| CA2329005C (fr) * | 1998-04-17 | 2006-01-03 | Ortho-Mcneil Pharmaceutical, Inc. | Compositions pharmaceutiques contenant de l'acide folique, procedes et systemes d'administration correspondants |
| US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| CH693905A5 (de) * | 1999-04-15 | 2004-04-15 | Eprova Ag | Stabile kristalline Salze von 5-Methyltetrahydrofolsäure. |
| US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
| US20030092658A1 (en) * | 2001-02-02 | 2003-05-15 | Meyers Rachel E. | Novel human enzyme family members and uses thereof |
| WO2001077139A1 (fr) * | 2000-04-12 | 2001-10-18 | Schering Aktiengesellschaft | Estratrienes a substitution 8.beta-hydrocarbyle utilises comme oestrogenes a action selective |
| EP1216712A1 (fr) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Complexes d'inclusion de drospirenone et de cyclodextrines |
| EP1390038A2 (fr) * | 2001-05-16 | 2004-02-25 | Endeavor Pharmaceuticals | Traitement d'etats lies a un deficit en hormones par administration de progestatifs |
| CN1473035B (zh) * | 2001-07-27 | 2012-07-18 | 安斯泰来制药有限公司 | 含有口腔内迅速崩解片剂用缓释微粒的组合物及其制造方法 |
| DE10207394B4 (de) * | 2002-02-21 | 2007-03-29 | Lts Lohmann Therapie-Systeme Ag | Geschmacksmaskierte oblatenförmige Arzneizubereitung |
| JP5037779B2 (ja) * | 2002-02-21 | 2012-10-03 | バイエル ファーマ アクチエンゲゼルシャフト | 1又は複数のステロイド、1又は複数のテトラヒドロ葉酸成分およびビタミンb12を含む医薬組成物 |
| US20070059346A1 (en) * | 2003-07-01 | 2007-03-15 | Todd Maibach | Film comprising therapeutic agents |
| KR20060126688A (ko) * | 2003-12-09 | 2006-12-08 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 약물-함유 입자 및 그 입자를 함유하는 고형 제제 |
| MY142989A (en) * | 2004-03-10 | 2011-02-14 | Bayer Schering Pharma Ag | Stabilised supersaturated solids of lipophilic drugs |
| US20050220825A1 (en) * | 2004-03-10 | 2005-10-06 | Adrian Funke | Molecular dispersions of drospirenone |
| DE102004023984A1 (de) * | 2004-05-14 | 2005-12-08 | Hf Arzneimittelforschung Gmbh | Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol |
| US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
| DE102005015128B4 (de) * | 2005-03-31 | 2008-12-11 | Bayer Schering Pharma Aktiengesellschaft | Wafer enthaltend Steroidhormone |
| US20060275364A1 (en) * | 2005-05-26 | 2006-12-07 | Ahmed Salah U | Flexible Solid Dosage Forms and Methods of Making and Using the Same |
| DE102005058569B4 (de) * | 2005-12-08 | 2010-07-15 | Lts Lohmann Therapie-Systeme Ag | Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer |
| DE102005062270A1 (de) * | 2005-12-24 | 2007-06-28 | Bayer Technology Services Gmbh | Geschmacksmaskierung von Pulvern |
| DE102006003512A1 (de) * | 2006-01-24 | 2007-08-02 | Bayer Schering Pharma Ag | Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen |
| EP1867321A3 (fr) * | 2006-06-07 | 2008-11-19 | Familplan Consulting Ltd. | Produit pharmaceutique adapté à l'administration transmucosale orale comportant un agent pharmaceutique |
| DE102006027796A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Estrogen-Gestagen-Kombinationen |
| DE102006027792A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Antidepressiva-Kombinations-Wafer |
| US20080058272A1 (en) * | 2006-08-29 | 2008-03-06 | Juergen Becker | Nonamer Peptides for Cancer Treatment |
-
2009
- 2009-02-05 CA CA2714340A patent/CA2714340A1/fr not_active Abandoned
- 2009-02-05 JP JP2010546291A patent/JP2011511823A/ja not_active Withdrawn
- 2009-02-05 WO PCT/EP2009/051303 patent/WO2009101021A2/fr not_active Ceased
- 2009-02-05 NZ NZ586666A patent/NZ586666A/en not_active IP Right Cessation
- 2009-02-05 EP EP09709466A patent/EP2249803A2/fr not_active Withdrawn
- 2009-02-05 AU AU2009214193A patent/AU2009214193A1/en not_active Abandoned
- 2009-02-05 KR KR1020107020216A patent/KR20100125309A/ko not_active Withdrawn
- 2009-02-05 MX MX2010008940A patent/MX2010008940A/es unknown
- 2009-02-05 EA EA201001245A patent/EA201001245A1/ru unknown
- 2009-02-05 BR BRPI0908477A patent/BRPI0908477A2/pt not_active IP Right Cessation
- 2009-02-05 CN CN2009801052091A patent/CN101945646A/zh active Pending
- 2009-02-05 US US12/867,409 patent/US20110097405A1/en not_active Abandoned
- 2009-02-10 UA UAA201010636A patent/UA102680C2/ru unknown
- 2009-02-13 UY UY031660A patent/UY31660A1/es not_active Application Discontinuation
- 2009-02-13 PE PE2009000219A patent/PE20091471A1/es not_active Application Discontinuation
- 2009-02-13 PA PA20098816001A patent/PA8816001A1/es unknown
- 2009-02-13 CL CL2009000326A patent/CL2009000326A1/es unknown
- 2009-02-13 AR ARP090100515A patent/AR070375A1/es not_active Application Discontinuation
- 2009-02-13 TW TW098104745A patent/TW200940095A/zh unknown
-
2010
- 2010-06-27 IL IL206640A patent/IL206640A0/en unknown
- 2010-06-30 TN TN2010000302A patent/TN2010000302A1/fr unknown
- 2010-08-12 MA MA33078A patent/MA32073B1/fr unknown
- 2010-08-12 EC EC2010010400A patent/ECSP10010400A/es unknown
- 2010-08-13 CO CO10100017A patent/CO6290633A2/es not_active Application Discontinuation
- 2010-08-13 CR CR11632A patent/CR11632A/es not_active Application Discontinuation
- 2010-08-13 DO DO2010000252A patent/DOP2010000252A/es unknown
- 2010-09-10 ZA ZA2010/06517A patent/ZA201006517B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101945646A (zh) | 2011-01-12 |
| TN2010000302A1 (en) | 2011-11-11 |
| JP2011511823A (ja) | 2011-04-14 |
| EP2249803A2 (fr) | 2010-11-17 |
| ECSP10010400A (es) | 2010-09-30 |
| CO6290633A2 (es) | 2011-06-20 |
| CR11632A (es) | 2010-10-05 |
| CA2714340A1 (fr) | 2009-08-20 |
| MX2010008940A (es) | 2010-10-05 |
| DOP2010000252A (es) | 2010-08-31 |
| TW200940095A (en) | 2009-10-01 |
| US20110097405A1 (en) | 2011-04-28 |
| WO2009101021A3 (fr) | 2009-12-30 |
| ZA201006517B (en) | 2014-02-26 |
| NZ586666A (en) | 2012-04-27 |
| AR070375A1 (es) | 2010-03-31 |
| PE20091471A1 (es) | 2009-10-25 |
| IL206640A0 (en) | 2010-12-30 |
| BRPI0908477A2 (pt) | 2018-03-27 |
| CL2009000326A1 (es) | 2010-07-19 |
| PA8816001A1 (es) | 2009-09-17 |
| KR20100125309A (ko) | 2010-11-30 |
| EA201001245A1 (ru) | 2011-04-29 |
| WO2009101021A2 (fr) | 2009-08-20 |
| AU2009214193A1 (en) | 2009-08-20 |
| UA102680C2 (ru) | 2013-08-12 |
| UY31660A1 (es) | 2009-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA32538B1 (fr) | Système d'administration de médicament contenant du progestatif | |
| MA34296B1 (fr) | Composition retard injectable antipsychotique | |
| NZ602698A (en) | Parenteral pharmaceutical form which releases aromatase inhibitor and gestagens, for the treatment of endometriosis | |
| EP2248519A3 (fr) | Formes galéniques de film non mucoadhésifs | |
| FR19C1030I1 (fr) | Systeme d'administration de medicament pour administrer des substances pharmaceutiquement actives pauvrement hydrosolubles | |
| EA201400056A1 (ru) | Вещества, связывающие ядерные рецепторы | |
| MA33533B1 (fr) | Compositions pharmaceutiques pour le traitement du cancer et d'autres maladies ou troubles | |
| MA29662B1 (fr) | Compositions pour l'apport de medicaments hautement solubles dans l'eau | |
| WO2008021113A3 (fr) | Méthodes transdermiques et systèmes pour traiter la maladie d'alzheimer | |
| MA54411B1 (fr) | Compositions contenant de l'ibrutinib | |
| WO2009039397A3 (fr) | Amides substitués, procédé pour les préparer et procédé pour les utiliser | |
| MD20070267A (en) | Gastroresistant pharmaceutical formulation containing rifaximin | |
| WO2007095091A3 (fr) | Administration orale d'agents thérapeutiques utilisant des agonistes à jonctions serrées | |
| MA32568B1 (fr) | Formulations pharmaceutiques contenant des ligands de recepteur de dopamine | |
| WO2009032034A3 (fr) | Forme posologique de picoplatine stabilisée | |
| MA33060B1 (fr) | Formulations galéniques de composés organiques | |
| TW200833372A (en) | Use of (meth)acrylate copolymers in delayed-release pharmaceutical forms for decreasing the influence of ethanol on the release of active compound | |
| EP4282414A3 (fr) | Formulations de comprimés à libération modifiée contenant des inhibiteurs de phosphodiestérase | |
| WO2007092469A3 (fr) | Combinaison de composes organiques | |
| PE20070329A1 (es) | Composiciones con estrogenos y metodos terapeuticos para su uso | |
| MA38694B1 (fr) | Dérivés thérapeutiquement actifs d'estratriène-thiazole à substitution azote en position 17 en tant qu'inhibiteurs de la 17bêta.-hydroxystéroïde déshydrogénase | |
| MX2013001637A (es) | Composiciones farmaceuticas de liberacion controlada oral de blonanserina. | |
| MA33602B1 (fr) | Composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipide | |
| EA200701923A1 (ru) | Лекарственная форма для перорального введения витамина | |
| MX2010008940A (es) | Sistemas de administracion de drogas que contienen estradiol. |